RNA methylation acts as a chemical switch that fine-tunes nearly every stage of a messenger RNA’s life after it has been copied from DNA. The most abundant of these switches in human cells is N6-methyladenosine, commonly called m6A, a small methyl group added to the nitrogen at position six of the adenosine base. Rather than altering the genetic code itself, m6A changes how the message is read, processed, stabilized, and eventually destroyed. Over 150 kinds of chemical modifications have been catalogued across cellular RNAs, but m6A stands out as the most widespread on messenger RNA in higher organisms, making it a central player in what researchers now call the epitranscriptome.
Where m6A Lands on RNA
m6A does not appear at random positions along an RNA strand. It preferentially marks adenosines that sit within a short sequence pattern known as DRACH, where D can be adenine, guanine, or uracil, R is a purine (adenine or guanine), A is the methylated adenosine itself, C is cytosine, and H is anything except guanine.1PubMed Central. Single-resolution mapping of m6A and m6Am throughout the transcriptome This consensus motif is widely conserved across eukaryotes, from yeast to plants to mammals, and tends to cluster near stop codons, in long internal exons, and in the untranslated regions flanking the coding sequence.2Biochemistry. The m6A Consensus Motif Provides a Paradigm of Epitranscriptomic Studies The same DRACH motif appears on viral RNA as well: studies on influenza A viruses have identified multiple m6A sites on hemagglutinin transcripts mapping to conserved DRACH sequences, suggesting that both host and pathogen share this modification code.3Scientific Reports. Evolutionary conservation of the DRACH signatures of potential N6-methyladenosine (m6A) sites among influenza A viruses
The non-random positioning matters because a methyl group near a stop codon has different functional consequences than one buried in the middle of a coding region. Researchers think of each m6A site as a context-dependent instruction: the same chemical mark can accelerate translation in one location, trigger degradation in another, or reroute splicing in a third. What determines the outcome is not the mark alone but the protein that reads it and where along the transcript the encounter takes place.
The Molecular Machinery Behind the Mark
Three families of proteins manage m6A, and researchers have nicknamed them writers, erasers, and readers. The metaphor is apt: writers install the methyl group, erasers remove it, and readers interpret the signal.
The main writer complex in human cells pairs two proteins called METTL3 and METTL14. Despite their similar names, they have very different jobs. METTL3 is the catalytically active partner, the one that actually transfers a methyl group from a donor molecule onto the target adenosine. METTL14, by contrast, plays a structural role, helping the complex recognize and bind the right RNA substrate. Mutating the catalytic site of METTL3 wipes out methylation activity entirely, whereas the equivalent mutation in METTL14 barely dents it as long as METTL3 is intact.4Molecular Cell. Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases Recent work has shed light on how METTL3 actually carries out the methyl transfer: specific amino acid side chains in its active site recruit the adenosine, stabilize the transition state, and then release the finished m6A product, with product release appearing to be the slowest step in the whole cycle.5PubMed Central. The catalytic mechanism of the RNA methyltransferase METTL3
On the eraser side, two enzymes dominate: FTO and ALKBH5. Both strip methyl groups from m6A, but they do so through surprisingly different chemical routes. ALKBH5 converts m6A directly back to unmodified adenosine in a single step, releasing formaldehyde rapidly. FTO, on the other hand, first converts m6A to an intermediate called hydroxymethyladenosine and only slowly proceeds to adenosine, releasing formaldehyde much more gradually.6PubMed Central. Distinct RNA N-demethylation pathways catalyzed by nonheme iron ALKBH5 and FTO enzymes enable regulation of formaldehyde release rates The existence of these erasers is what makes m6A a reversible, dynamic modification rather than a permanent stamp. A transcript can gain methylation in one cellular context and lose it in another, allowing the cell to reprogram gene expression without changing the underlying DNA.7PubMed Central. Insights into the m6A demethylases FTO and ALKBH5: structural, biological function, and inhibitor development
Readers are the proteins that actually translate the methyl mark into a biological outcome. The best-studied belong to the YTH domain family, particularly YTHDF1, YTHDF2, and YTHDF3, along with their nuclear relative YTHDC1. Although all of them recognize m6A through a shared structural pocket, their functions diverge considerably. That divergence stems from differences in their low-complexity protein regions outside the binding pocket, which dictate which other cellular partners they recruit and what downstream effect they trigger.8PubMed Central. The YTHDF proteins display distinct cellular functions on m6A-modified RNA
Reshaping the Message Through Splicing
Before a messenger RNA leaves the nucleus, it goes through editing: non-coding stretches called introns are cut out and coding stretches called exons are stitched together. Which exons get included or excluded in the final product is called alternative splicing, and it massively expands the number of distinct proteins a single gene can produce. m6A turns out to be an important regulator of these splicing decisions.
The nuclear reader YTHDC1 is central to this process. It binds m6A-marked sites on pre-mRNA and recruits a splicing factor called SRSF3, which promotes the inclusion of nearby exons. At the same time, YTHDC1 blocks a competing factor, SRSF10, which would otherwise favor exon skipping. The net effect is that methylated transcripts tend to include more exons than their unmethylated counterparts.9Molecular Cell. Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing More broadly, m6A can modulate alternative splicing patterns by recruiting various RNA-binding proteins or by reshaping the local RNA structure so that binding sites become exposed or hidden.10PubMed Central. Crosstalk between m6A modification and alternative splicing during cancer progression The result is that a single methyl group, placed at the right position, can change which version of a protein the cell ultimately makes.
Speeding Up or Slowing Down Protein Production
Once a mature mRNA reaches the cytoplasm, ribosomes begin translating it into protein. m6A influences how efficiently that translation proceeds, and the direction of the effect depends on where the mark sits and which reader protein engages it.
YTHDF1 appears to boost translation by accelerating the rate at which ribosomes begin reading a message. Experiments depleting YTHDF1 showed increased ribosome pileups at translation start sites, suggesting that without YTHDF1 the ribosome stalls during initiation. YTHDF1 seems to function not just by delivering more mRNA copies to the ribosome, but by speeding up the initiation step itself on already ribosome-bound messages.11Cell. N6-Methyladenosine-Dependent Regulation of Messenger RNA Stability
When m6A falls within the protein-coding region rather than the untranslated flanks, a different effect can emerge. A study tracking ribosome positions across the transcriptome found roughly threefold higher ribosome density at methylated codons sitting in the ribosomal decoding center, suggesting that m6A slows codon reading at those specific spots. The nuclear reader YTHDC2, which contains a built-in RNA helicase, helps resolve this tension by unwinding RNA structures that would otherwise impede ribosome progress through methylated coding regions.12Nature Communications. m6A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2 So m6A can simultaneously slow reading at one position and, through reader recruitment, enable the ribosome to power through secondary structures elsewhere on the same transcript. The overall translational output is a net calculation of these opposing forces.
Deciding Which Messages Survive
Perhaps the best-understood role of m6A is in targeting transcripts for destruction. The reader YTHDF2 is the main executioner. It recognizes m6A-marked mRNAs and funnels them into at least two distinct degradation routes. In one pathway, YTHDF2 recruits a deadenylase complex that chews away the poly-A tail, a protective structure at the end of the RNA, leading to rapid decay. In the other, YTHDF2 teams up with an adaptor protein and an endonuclease that cuts the RNA internally.13PubMed. Molecular Mechanisms Driving mRNA Degradation by m(6)A Modification
This system gives cells a fast and selective way to clear specific transcripts. Instead of waiting for an mRNA to decay naturally over hours, the cell can tag it with m6A and reduce its half-life dramatically. During events like the stress response, immune activation, or cell differentiation, rapid shifts in m6A patterns allow the cell to remodel its protein output on a timeline that transcription alone could not achieve.
Phase Separation and Cellular Organization
An unexpected twist in m6A biology is its ability to influence how the cell organizes itself physically. Cells contain membrane-less compartments such as stress granules and P-bodies, which form through a process called phase separation, somewhat like oil droplets condensing out of water. RNAs carrying multiple m6A marks serve as scaffolds that dramatically enhance this phase separation. When several YTHDF reader proteins bind to a single heavily methylated transcript, their low-complexity protein tails are brought into close proximity, and those clustered tails drive droplet formation.14PubMed Central. m6A enhances the phase separation potential of mRNA
A single m6A mark is not enough to trigger this condensation; it takes multiple methylation sites on the same RNA to create the multivalent scaffold needed. The resulting RNA-protein complexes then sort themselves into different compartments depending on the cellular context. This means m6A not only controls individual transcript fate but also helps organize the broader spatial landscape of gene regulation inside the cell.
Beyond m6A: Other RNA Modifications That Matter
m6A dominates the conversation, but it is not the only post-transcriptional modification with regulatory teeth. 5-methylcytosine (m5C) is another well-studied mark, installed by its own set of methyltransferases and removed by its own demethylases. Like m6A, m5C influences splicing, nuclear export, translation, and stability, and it has increasingly been linked to cancer drug resistance.15PubMed Central. 5-Methylcytosine RNA modification and its roles in cancer and cancer chemotherapy resistance Intriguingly, the m6A and m5C systems do not operate in isolation. Proteomic data have revealed co-regulatory feedback loops between their respective writer, eraser, and reader proteins, including cross-talk that converges on brain disease pathways.16PubMed Central. Global Co-regulatory Cross Talk Between m6A and m5C RNA Methylation Systems Coordinate Cellular Responses and Brain Disease Pathways
Internal N7-methylguanosine (m7G) is another modification drawing attention. While the m7G cap at the very start of every mRNA has been known for decades, researchers have now found m7G marks placed inside the body of transcripts as well. The methyltransferase METTL1 installs these internal marks, and depleting METTL1 reduces the translation efficiency of its target transcripts, suggesting that internal m7G acts as a translational enhancer for a subset of mRNAs.17Molecular Cell. Internal N7-Methylguanosine Methylation of Mammalian mRNA and Its Translation Regulation The emerging picture is one of a layered epitranscriptomic code, with different chemical marks interacting, sometimes cooperating and sometimes competing, to tune gene expression.
Brain Development and Stem Cell Self-Renewal
Some of the most dramatic biological consequences of m6A loss show up during brain development. When researchers deleted the m6A writer Mettl14 in mouse embryonic neural stem cells, those cells stopped proliferating normally and instead differentiated prematurely. In living embryos, the loss of Mettl14 led to fewer radial glial cells in the developing brain’s ventricular zone and a reduction in the cortical neurons those progenitors were supposed to generate.18Nature Neuroscience. N6-methyladenosine RNA modification regulates embryonic neural stem cell self-renewal through histone modifications The finding underscores that m6A is not a subtle fine-tuning mechanism in every context; in neural development, it is essential for maintaining the balance between stem cell self-renewal and differentiation. Disrupting that balance leads to structural brain defects.
This connection extends to the mitochondria as well. m6A promotes the translation of nuclear-encoded subunits of the mitochondrial electron transport chain, linking RNA methylation to cellular energy production.19PubMed Central. m6A RNA methylation regulates mitochondrial function Neurons, which are famously hungry for energy, may be especially vulnerable when m6A is disrupted.
Cancer and the Double-Edged Sword of Dysregulation
Given that m6A controls mRNA fate at so many levels, it is no surprise that its dysregulation surfaces in cancer. Both overactive and underactive m6A machinery have been linked to tumor biology. In some cancers, elevated METTL3 activity methylates transcripts of growth-promoting genes, stabilizing them or boosting their translation. In others, loss of m6A on tumor-suppressor transcripts tips the balance toward uncontrolled proliferation.20PubMed Central. The role of m(6)A RNA methylation in human cancer The same machinery can act as oncogene or tumor suppressor depending on the tissue, the specific transcripts affected, and the broader signaling environment of the cell.
This complexity matters for therapy. A drug that blanket-inhibits m6A writing might curb tumor growth in one cancer type while fueling it in another. That said, the first selective METTL3 inhibitor, a compound called STC-15, has advanced into a phase 1b/2 clinical trial in cancer patients, marking the first time pharmacological targeting of the m6A writing machinery has been tested in humans.21PubMed. Small-Molecule Inhibitors Targeting RNA m(6)A Modifiers for Cancer Therapeutics: Latest Advances and Future Perspectives Early clinical results will reveal whether the therapeutic window is wide enough to exploit m6A dependence in tumor cells without unacceptable side effects in normal tissue.
How Researchers Map m6A Across the Transcriptome
Much of what we know about m6A relies on the tools used to detect it, and those tools have evolved rapidly. The earliest transcriptome-wide approaches used antibodies against m6A to pull down methylated RNA fragments, then sequenced those fragments. This method, called MeRIP-seq, revealed the broad landscape of m6A but could only pinpoint sites to a resolution of about 100–200 nucleotides, not individual bases.
Nanopore direct RNA sequencing has changed the game. By threading native RNA strands through a protein pore and measuring electrical current disruptions, nanopore platforms can detect m6A without any chemical treatment or antibody enrichment. Pipelines built on machine-learning models now identify and quantify m6A at single-base resolution.22PubMed Central. Quantitative profiling of N(6)-methyladenosine at single-base resolution in stem-differentiating xylem of Populus trichocarpa using Nanopore direct RNA sequencing A systematic comparison of ten different nanopore-based m6A mapping tools found that most present a trade-off between precision and recall, and combining results from multiple tools substantially improves accuracy.23Nature Communications. Systematic comparison of tools used for m6A mapping from nanopore direct RNA sequencing The field is still converging on gold-standard approaches, and discrepancies between methods remain a genuine source of confusion when comparing studies.
Viruses, Host Defense, and Borrowed Methylation
Viruses that replicate in the nucleus or use host machinery to process their RNA acquire m6A modifications through the same METTL3-METTL14 writer complex that methylates cellular mRNA. This creates a fascinating tug-of-war. On one hand, m6A on viral transcripts can enhance viral protein production and help the virus evade immune detection by mimicking the host epitranscriptomic signature. On the other hand, the host immune system can use m6A patterning as a way to distinguish self from non-self RNA, flagging foreign transcripts that carry unusual methylation patterns for immune sensing.24PubMed Central. m6A Methylation in Regulation of Antiviral Innate Immunity
Some viruses have apparently evolved to optimize their DRACH motifs for host methylation, effectively camouflaging their RNA. Whether therapeutic manipulation of m6A could tip this balance in favor of the host is an open question, though it is constrained by the obvious problem that the host’s own mRNAs depend on the same machinery.
RNA Methylation in Plants
m6A is not an animal invention. Plants possess a conserved set of writers, erasers, and readers, and work in model species like Arabidopsis has shown that m6A is essential for normal development, stress responses, and reproductive timing. The evolutionary relationships between plant and animal m6A components are highly conserved across the plant kingdom, reinforcing the idea that this system was present in the common ancestor of all eukaryotes.25PubMed Central. N6-methyladenosine regulatory machinery in plants: composition, function and evolution Plant biologists are particularly interested in how m6A responds to environmental cues like drought, heat, and pathogen attack, since post-transcriptional regulation is especially important for organisms that cannot move away from stressors.
An Ancient System With a Deep Evolutionary Root
Comparative analysis of m6A-associated proteins across distant branches of life suggests that the entire m6A system originated in the last eukaryotic common ancestor, or LECA. That ancestral toolkit appears to have included one METTL3-METTL14 writer pair, auxiliary proteins like WTAP and RBM15, one YTHDC and one YTHDF reader, and one FTO and one ALKBH5 eraser. Critically, homologues of these proteins are found only in eukaryotic genomes, not in prokaryotes, suggesting the system arose after the prokaryote-eukaryote split.26PubMed Central. Evolutionary History of RNA Modifications at N6-Adenosine Originating from the R-M System in Eukaryotes and Prokaryotes From that compact starting point, different lineages expanded and diversified their m6A machinery, duplicating reader and writer genes and repurposing them for tissue-specific or developmental-stage-specific functions. The deep conservation explains why disrupting a single writer can have such sweeping consequences: cells have relied on this regulatory layer for well over a billion years, and modern gene expression programs are thoroughly entangled with it.